Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumiyuki Takahashi

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2013
Reply to A. Berti et alKatsutoshi Ando, Fumiyuki Takahashi, Kazuhisa Takahashi
Respiratory Investigation|October 9, 2018
Resistance to molecularly targeted therapy in non-small-cell lung cancerTetsuhiko Asao, Fumiyuki Takahashi, Kazuhisa Takahashi
Journal of Natural Science, Biology, and Medicine|July 20, 2016
Gefitinib in the treatment of nonsmall cell lung cancer with activating epidermal growth factor receptor mutationFariz Nurwidya, Fumiyuki Takahashi, Kazuhisa Takahashi
Thoracic Cancer|September 19, 2017
Meeting report: Current cancer perspectives from the 9<sup>th</sup> Annual Meeting of the Japanese Society of Medical OncologyFariz Nurwidya, Fumiyuki Takahashi, Kazuhisa Takahashi
Cancer Biology & Medicine|May 22, 2013
Molecular mechanisms contributing to resistance to tyrosine kinase-targeted therapy for non-small cell lung cancerFariz Nurwidya, Akiko Murakami, Fumiyuki Takahashi, et al.
Asia-Pacific Journal of Clinical Oncology|August 18, 2012
Lung cancer stem cells: tumor biology and clinical implicationsFariz Nurwidya, Akiko Murakami, Fumiyuki Takahashi, et al.
Cancer Research and Treatment|October 24, 2012
Epithelial mesenchymal transition in drug resistance and metastasis of lung cancerFariz Nurwidya, Fumiyuki Takahashi, Akiko Murakami, et al.
Anatomy & Cell Biology|July 24, 2012
From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancersFariz Nurwidya, Fumiyuki Takahashi, Kunihiko Minakata, et al.
The Malaysian Journal of Medical Sciences : MJMS|July 16, 2016
Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung CancerFariz Nurwidya, Sita Andarini, Fumiyuki Takahashi, et al.
Lung Cancer (Amsterdam, Netherlands)|July 23, 2003
Restoration of CD44S in non-small cell lung cancer cells enhanced their susceptibility to the macrophage cytotoxicityKazuhisa Takahashi, Fumiyuki Takahashi, Michihiro Hirama, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2013
Reply to A. Berti et alKatsutoshi Ando, Fumiyuki Takahashi, Kazuhisa Takahashi
Respiratory Investigation|October 9, 2018
Resistance to molecularly targeted therapy in non-small-cell lung cancerTetsuhiko Asao, Fumiyuki Takahashi, Kazuhisa Takahashi
Journal of Natural Science, Biology, and Medicine|July 20, 2016
Gefitinib in the treatment of nonsmall cell lung cancer with activating epidermal growth factor receptor mutationFariz Nurwidya, Fumiyuki Takahashi, Kazuhisa Takahashi
Thoracic Cancer|September 19, 2017
Meeting report: Current cancer perspectives from the 9<sup>th</sup> Annual Meeting of the Japanese Society of Medical OncologyFariz Nurwidya, Fumiyuki Takahashi, Kazuhisa Takahashi
Cancer Biology & Medicine|May 22, 2013
Molecular mechanisms contributing to resistance to tyrosine kinase-targeted therapy for non-small cell lung cancerFariz Nurwidya, Akiko Murakami, Fumiyuki Takahashi, et al.
Asia-Pacific Journal of Clinical Oncology|August 18, 2012
Lung cancer stem cells: tumor biology and clinical implicationsFariz Nurwidya, Akiko Murakami, Fumiyuki Takahashi, et al.
Cancer Research and Treatment|October 24, 2012
Epithelial mesenchymal transition in drug resistance and metastasis of lung cancerFariz Nurwidya, Fumiyuki Takahashi, Akiko Murakami, et al.
Anatomy & Cell Biology|July 24, 2012
From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancersFariz Nurwidya, Fumiyuki Takahashi, Kunihiko Minakata, et al.
The Malaysian Journal of Medical Sciences : MJMS|July 16, 2016
Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung CancerFariz Nurwidya, Sita Andarini, Fumiyuki Takahashi, et al.
Lung Cancer (Amsterdam, Netherlands)|July 23, 2003
Restoration of CD44S in non-small cell lung cancer cells enhanced their susceptibility to the macrophage cytotoxicityKazuhisa Takahashi, Fumiyuki Takahashi, Michihiro Hirama, et al.
Pageof 13